What you're publishing I would actually call polymer supported therapeutics. Maybe it sounds less flashy than the nanorobots, but this is something that actually means something, and sure has a future (I can vaguely remember pharmaceuticals linked to PEG polymers already on the market). The thing is 'nanotech' means nothing in particular (simply imposing a size limit seems a little absurd to define a field of science), except in the imagination of the public. Maybe it forged some alliances between material scientists and organic/medicinal chemists.
Well, there are some cool aspects at that size scale. The rapid transport of water through carbon nanotube membranes come time mind right.
You are correct, as to the name of the field. Indeed, polymer based drug delivery and biomaterials is my exact area. Also, you can say that nanomedicines are on the market (PEGylated liposomes loaded with doxorubicin)
I will say, though that the stuff I'm working on has had enough unique size characteristics, that the name isn't so terrible.
For instance, the worm-like micelles (due to the high aspect ratio) flow allign in circulation and are capable of evading macrophage clearence. this has resulted in enhanced circulation times over what is seen with purely PEGylated proteins and PEGylated spherical counterparts.
Further, when you get to cell response, size is everything. >500nm or larger, endothelial cells don't internalized carriers very readily(if at all). However if you taget 300nm or less carriers, you can get extremely high levels of internalization.
I'll admit, though, this this is simply in vitro observations. I have no clue if it translates to what occurs in vivo yet.
As another aside, my current work has switched a bit from enzyme delivery to polymeric prodrugs. Just out of interest.